Search Results - "Carubbi, F."

Refine Results
  1. 1

    Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology by Loria, P, Marchesini, G, Nascimbeni, F, Ballestri, S, Maurantonio, M, Carubbi, F, Ratziu, V, Lonardo, A

    Published in Atherosclerosis (01-01-2014)
    “…Abstract Background Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from…”
    Get full text
    Journal Article
  2. 2

    H‐ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome by Ruscitti, P., Cipriani, P., Di Benedetto, P., Liakouli, V., Berardicurti, O., Carubbi, F., Ciccia, F., Guggino, G., Triolo, G., Giacomelli, R.

    Published in Clinical and experimental immunology (01-02-2018)
    “…Summary Macrophage activation syndrome (MAS) is hyperinflammatory life‐threatening syndrome, associated typically with high levels of serum ferritin. This is…”
    Get full text
    Journal Article
  3. 3

    A rare case of symptomatic creatine kinase elevation in a patient with rheumatoid arthritis treated with baricitinib by Mariani, F M, Alunno, A, Carubbi, F, Ferri, C

    Published in Reumatismo (24-06-2024)
    “…The safety profile of baricitinib (BARI), a Janus kinase inhibitor broadly used for the treatment of rheumatoid arthritis (RA), includes asymptomatic…”
    Get full text
    Journal Article
  4. 4

    Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study by Bartoloni, E., Baldini, C., Schillaci, G., Quartuccio, L., Priori, R., Carubbi, F., Bini, V., Alunno, A., Bombardieri, S., De Vita, S., Valesini, G., Giacomelli, R., Gerli, R.

    Published in Journal of internal medicine (01-08-2015)
    “…Objective Systemic autoimmune diseases, in particular systemic lupus erythematosus and rheumatoid arthritis, are characterized by a high risk of premature…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Interleukin‐36α axis is modulated in patients with primary Sjögren's syndrome by Ciccia, F., Accardo‐Palumbo, A., Alessandro, R., Alessandri, C., Priori, R., Guggino, G., Raimondo, S., Carubbi, F., Valesini, G., Giacomelli, R., Rizzo, A., Triolo, G.

    Published in Clinical and experimental immunology (01-08-2015)
    “…Summary The aim of this study was to investigate the expression of the interleukin (IL)‐36 axis in patients with primary Sjögren's syndrome (pSS). Blood and…”
    Get full text
    Journal Article
  8. 8

    Interleukin-36[alpha] axis is modulated in patients with primary Sjögren's syndrome by Ciccia, F, Accardo-Palumbo, A, Alessandro, R, Alessandri, C, Priori, R, Guggino, G, Raimondo, S, Carubbi, F, Valesini, G, Giacomelli, R, Rizzo, A, Triolo, G

    Published in Clinical and experimental immunology (01-08-2015)
    “…Summary The aim of this study was to investigate the expression of the interleukin (IL)-36 axis in patients with primary Sjögren's syndrome (pSS). Blood and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome by Carubbi, F, Alunno, A, Cipriani, P, Bartoloni, E, Baldini, C, Quartuccio, L, Priori, R, Valesini, G, De Vita, S, Bombardieri, S, Gerli, R, Giacomelli, R

    Published in Lupus (01-03-2015)
    “…Objective The objective of this report is to investigate the prognostic value of minor salivary glands (MSG) assessment, routinely performed with…”
    Get full text
    Journal Article
  11. 11

    Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study by Alunno, A., Carubbi, F., Bistoni, O., Caterbi, S., Bartoloni, E., Di Benedetto, P., Cipriani, P., Giacomelli, R., Gerli, R.

    Published in Clinical and experimental immunology (01-06-2016)
    “…Summary Compelling evidence suggests that interleukin (IL)‐17 and IL‐17‐producing cells play a pivotal role in the pathogenesis of primary Sjögren's syndrome…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Histopathology of salivary glands by Carubbi, F, Alunno, A, Gerli, R, Giacomelli, R

    Published in Reumatismo (03-10-2018)
    “…Salivary gland (SG) biopsy is a technique broadly applied for the diagnosis of primary Sjögren's syndrome (pSS), lymphoma accompanying SS, sarcoidosis,…”
    Get full text
    Journal Article Book Review
  15. 15
  16. 16
  17. 17

    Rituximab in primary Sjögren's syndrome: a ten-year journey by Carubbi, F, Alunno, A, Cipriani, P, Bartoloni, E, Ciccia, F, Triolo, G, Gerli, R, Giacomelli, R

    Published in Lupus (01-11-2014)
    “…Primary Sjögren's syndrome (pSS) is an autoimmune disorder affecting exocrine glands and characterized in most cases by a rather mild clinical picture…”
    Get full text
    Book Review Journal Article
  18. 18
  19. 19

    Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A‐V deficiency due to a novel mutation in the APOA5 gene by Oliva, C. Priore, Carubbi, F., Schaap, F. G., Bertolini, S., Calandra, S.

    Published in Journal of internal medicine (01-04-2008)
    “… APOA5 encodes a novel apolipoprotein (apo A‐V) which appears to be a modulator of plasma triglyceride (TG). In apoA5 knock out mice plasma TG level increases…”
    Get full text
    Journal Article
  20. 20